Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)
Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection